Drugs for the Heart

Front Cover
Lionel H. Opie, Bernard J. Gersh
Elsevier Saunders, 2005 - Medical - 437 pages
0 Reviews
The new 6th Edition continues to be the definitive pocket-sized guide on the "hows" and "whys" of cardiovascular drugs. It provides in-depth information on all of the drug classes used to treat heart disease, and covers drug use, new drug classes, drug use for single and multiple problem management, and more. A user-friendly organization speed readers to the information they need, and dynamic new full-color drawings illustrate key pharmacological and physiological actions. The new edition includes access to the companion website, which offers bi-annual content updates to keep you current with new drugs, indications and leading trials. The website also has the feature of fully searchable text to access book content via drug, disease or drug action.

  • Features a final chapter, "Which Drugs for Which Disease" that provides a disease-based approach to drugs, complete with rationales and clinical data.
  • Includes clinical trial data for each drug class and type.

  • Discusses and evaluates new advances in drugs such as super statins as well as combination therapies.
  • Provides an increased emphasis on the practical use of drugs for busy clinicians.
  • Features a bold new full-color format, with enhanced illustrations that depict pharmacologic and physiologic actions.
  • Delivers information on new drug classes, including practical descriptions and guidance on the use of new drug agents.

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.


Calcium Channel Blockers

3 other sections not shown

Other editions - View all

Common terms and phrases

About the author (2005)

Lionel H. Opie, M.D., Ph.D., is Professor of Medicine at the University of Cape Town and Visiting Professor, Division of Cardiovascular Medicine, Stanford University Medical Center, California. After graduating from the University of Cape Town, he studied at Oxford as a Rhodes Scholar and was a Research Fellow at Harvard from 1959-1961. He became a Fellow of the Royal College of Physicians of London in 1974. From 1976-1978, he was President of the International Society for Heart Research. He is the author of The Heart: Physiology and Metabolism, Second Edition, 1991, and Angiotensin-Converting Enzyme Inhibitors: Scientific Basis for Clinical Use, 1992. He is Editor of Drugs for the Heart, Fourth Edition, in preparation for 1995. He is Co-Editor of Cardiovascular Drugs and Therapy. For 1990-1993, he was Chairman of the Committee on Cardiovascular Drugs of the International Society and Federation of Cardiology.

Bibliographic information